JY
YARW

Jeff Yass’s Yarrow Bioscience YARW Stock Holding History

Jeff Yass’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-54
Closed -$169K – 13667
2021
Q2 		$169K Sell
54
-8
-13% -$31.7K ﹤0.01% 11763
2021
Q1 		$383K Buy
+62
New +$450K ﹤0.01% 10081

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Jeff Yass's YARW Position: Q2 2026 in Review

Jeff Yass increased its Yarrow Bioscience (YARW) stake by 106% in Q2 2026, buying an estimated $39.7K and bringing the position to 2,379 shares worth $77.4K. The position accounts for ﹤0.01% of the portfolio, ranked #12649.

Jeff Yass first reported a position in YARW in Q1 2020 and has held it in 23 quarters since. The position peaked at $310K in Q2 2023. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Jeff Yass held 2,379 shares of Yarrow Bioscience worth $77.4K as of Q2 2026.
  • Jeff Yass bought 1,223 Yarrow Bioscience shares in Q2 2026, an estimated $39.7K.
  • Yarrow Bioscience made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12649 holding.
  • Jeff Yass first reported a position in Yarrow Bioscience in Q1 2020 and has held it in 23 quarters since.
  • Jeff Yass's Yarrow Bioscience position peaked at $310K in Q2 2023.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.